☆ 4.7 Article

A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)

Fredrik Waernberg et al.

Summary: Although clinical advancements in the diagnosis and treatment of ductal carcinoma in situ (DCIS) have been made, determining who will benefit from radiotherapy (RT) remains a challenge. DCISionRT is able to identify women at high risk of recurrence and provide beneficial RT treatment for them, while also determining that women at low risk of recurrence do not benefit significantly from RT.

CANCERS (2021)

添加到收藏夹

Article Oncology

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial

Melody A. Cobleigh et al.

Summary: The B-43 trial aimed to evaluate the efficacy of RT alone vs RT plus T in preventing IBTR in DCIS patients. The addition of T did not achieve the intended 36% reduction in IBTR rate, but did show a modest and statistically nonsignificant 19% reduction. Further exploration of RT plus T in HER2-positive DCIS patients is needed before routine delivery in patients with DCIS resected by lumpectomy.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804

Beryl McCormick et al.

Summary: NRG/RTOG 9804 is the only randomized trial assessing the impact of whole breast irradiation versus observation in women with good-risk ductal carcinoma in situ (DCIS) following lumpectomy. The study found that whole breast irradiation significantly reduced the risk of ipsilateral breast recurrence for DCIS with durable effects at 15 years.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy

Sheila Weinmann et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Review Oncology

Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions

Lawrence J. Solin

CURRENT ONCOLOGY REPORTS (2019)

添加到收藏夹

Review Oncology

Ductal carcinoma in situ: to treat or not to treat, that is the question

Maartje van Seijen et al.

BRITISH JOURNAL OF CANCER (2019)

添加到收藏夹

Article Oncology

A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk

Troy Bremer et al.

CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Article Medicine, General & Internal

SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer

Lauren L. Siewertsz van Reesema et al.

EBIOMEDICINE (2016)

添加到收藏夹

Article Oncology

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

Beryl McCormick et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

Lawrence J. Solin et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

Steven A. Narod et al.

JAMA ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS)

Julia S. Wong et al.

BREAST CANCER RESEARCH AND TREATMENT (2014)

添加到收藏夹

Article Oncology

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

Lawrence J. Solin et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

添加到收藏夹

Article Oncology

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

Lucia Hernandez et al.

JOURNAL OF PATHOLOGY (2012)

添加到收藏夹

Article Oncology

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

Irene L. Wapnir et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

添加到收藏夹

Editorial Material Oncology

National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009

Carmen J. Allegra et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

添加到收藏夹

Article Oncology

Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue

Rebecca L. Schmidt et al.

CANCER RESEARCH (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.